Trial Outcomes & Findings for Preoxygenation With Positive Inspiratory Pressure During Induction of Anesthesia (NCT NCT02313766)

NCT ID: NCT02313766

Last Updated: 2016-04-14

Results Overview

Time measured form face mask positioning until FEO2 reached 90% on the gas monitor

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

150 participants

Primary outcome timeframe

up to 5 min

Results posted on

2016-04-14

Participant Flow

Planned Recruitment period : from october 01,2006 to october 31,2007 The day of surgery, the patient was randomly allocated (random number table, equilibration block sizes of 15)

patients received oral information and signed a written informed consent at the end of the preanaesthesia medical consultation

Participant milestones

Participant milestones
Measure
Spontaneous Breathing (SB)
preoxygenation through a face mask firmly applied and connected to the anaesthesia machine delivering a fresh gas flow of 12 l min-1. The inspired O2 concentration was set at 100%. End of preoxygenation FEO2=90%
Positive Pressure Ventilation (PPV)
PPV : positive pressure ventilation : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) without PEEP. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=0 cmH2O End of preoxygenation FEO2=90% PPV : positive pressure ventilation: Inspiratory pressure support ventilation (12 cmH2O) without PEEP
PPV + PEEP
PEEP : PPV + PEEP : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) with PEEP at 6 cmH2O. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=6 cmH2O End of preoxygenation FEO2=90% PEEP : PPV + PEEP: Inspiratory pressure support ventilation (12 cmH2O) with PEEP (6 cmH2O)
Overall Study
STARTED
50
50
50
Overall Study
COMPLETED
49
47
50
Overall Study
NOT COMPLETED
1
3
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Spontaneous Breathing (SB)
preoxygenation through a face mask firmly applied and connected to the anaesthesia machine delivering a fresh gas flow of 12 l min-1. The inspired O2 concentration was set at 100%. End of preoxygenation FEO2=90%
Positive Pressure Ventilation (PPV)
PPV : positive pressure ventilation : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) without PEEP. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=0 cmH2O End of preoxygenation FEO2=90% PPV : positive pressure ventilation: Inspiratory pressure support ventilation (12 cmH2O) without PEEP
PPV + PEEP
PEEP : PPV + PEEP : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) with PEEP at 6 cmH2O. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=6 cmH2O End of preoxygenation FEO2=90% PEEP : PPV + PEEP: Inspiratory pressure support ventilation (12 cmH2O) with PEEP (6 cmH2O)
Overall Study
surgery cancelled
1
0
0
Overall Study
Lost to Follow-up
0
2
0
Overall Study
Adverse Event
0
1
0

Baseline Characteristics

Preoxygenation With Positive Inspiratory Pressure During Induction of Anesthesia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Spontaneous Breathing (SB)
n=49 Participants
preoxygenation through a face mask firmly applied and connected to the anaesthesia machine delivering a fresh gas flow of 12 l min-1. The inspired O2 concentration was set at 100%. End of preoxygenation FEO2=90%
Positive Pressure Ventilation (PPV)
n=47 Participants
PPV : positive pressure ventilation : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) without PEEP. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=0 cmH2O End of preoxygenation FEO2=90% PPV : positive pressure ventilation: Inspiratory pressure support ventilation (12 cmH2O) without PEEP
PPV + PEEP
n=50 Participants
PEEP : PPV + PEEP : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) with PEEP at 6 cmH2O. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=6 cmH2O End of preoxygenation FEO2=90% PEEP : PPV + PEEP: Inspiratory pressure support ventilation (12 cmH2O) with PEEP (6 cmH2O)
Total
n=146 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
42 Participants
n=5 Participants
42 Participants
n=7 Participants
41 Participants
n=5 Participants
125 Participants
n=4 Participants
Age, Categorical
>=65 years
7 Participants
n=5 Participants
5 Participants
n=7 Participants
9 Participants
n=5 Participants
21 Participants
n=4 Participants
Age, Continuous
45 years
STANDARD_DEVIATION 18 • n=5 Participants
40 years
STANDARD_DEVIATION 17 • n=7 Participants
45 years
STANDARD_DEVIATION 20 • n=5 Participants
44 years
STANDARD_DEVIATION 19 • n=4 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
24 Participants
n=7 Participants
20 Participants
n=5 Participants
66 Participants
n=4 Participants
Sex: Female, Male
Male
27 Participants
n=5 Participants
23 Participants
n=7 Participants
30 Participants
n=5 Participants
80 Participants
n=4 Participants
Region of Enrollment
France
49 participants
n=5 Participants
47 participants
n=7 Participants
50 participants
n=5 Participants
146 participants
n=4 Participants

PRIMARY outcome

Timeframe: up to 5 min

Time measured form face mask positioning until FEO2 reached 90% on the gas monitor

Outcome measures

Outcome measures
Measure
Spontaneous Breathing (SB)
n=49 Participants
preoxygenation through a face mask firmly applied and connected to the anaesthesia machine delivering a fresh gas flow of 12 l min-1. The inspired O2 concentration was set at 100%. End of preoxygenation FEO2=90%
Positive Pressure Ventilation (PPV)
n=47 Participants
PPV : positive pressure ventilation : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) without PEEP. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=0 cmH2O End of preoxygenation FEO2=90% PPV : positive pressure ventilation: Inspiratory pressure support ventilation (12 cmH2O) without PEEP
PPV + PEEP
n=50 Participants
PEEP : PPV + PEEP : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) with PEEP at 6 cmH2O. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=6 cmH2O End of preoxygenation FEO2=90% PEEP : PPV + PEEP: Inspiratory pressure support ventilation (12 cmH2O) with PEEP (6 cmH2O)
Time for Preoxygenationfrom Face Mask Positioning to FEO2=90%
190 seconds
Interval 130.0 to 264.0
153 seconds
Interval 120.0 to 218.0
140 seconds
Interval 100.0 to 200.0

SECONDARY outcome

Timeframe: up to 10 min

time until SpO2=93% after endotracheal tube placement has been confirmed

Outcome measures

Outcome measures
Measure
Spontaneous Breathing (SB)
n=49 Participants
preoxygenation through a face mask firmly applied and connected to the anaesthesia machine delivering a fresh gas flow of 12 l min-1. The inspired O2 concentration was set at 100%. End of preoxygenation FEO2=90%
Positive Pressure Ventilation (PPV)
n=47 Participants
PPV : positive pressure ventilation : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) without PEEP. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=0 cmH2O End of preoxygenation FEO2=90% PPV : positive pressure ventilation: Inspiratory pressure support ventilation (12 cmH2O) without PEEP
PPV + PEEP
n=50 Participants
PEEP : PPV + PEEP : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) with PEEP at 6 cmH2O. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=6 cmH2O End of preoxygenation FEO2=90% PEEP : PPV + PEEP: Inspiratory pressure support ventilation (12 cmH2O) with PEEP (6 cmH2O)
Time Until SpO2=93%
305 seconds
Interval 263.0 to 383.0
370 seconds
Interval 300.0 to 450.0
345 seconds
Interval 245.0 to 435.0

SECONDARY outcome

Timeframe: Before PACU leaving

discomfort of the preoxygenation phase evaluated on a visual analogue scale (0 no discomfort - 100 maximal discomfort) just before PACU leaving

Outcome measures

Outcome measures
Measure
Spontaneous Breathing (SB)
n=49 Participants
preoxygenation through a face mask firmly applied and connected to the anaesthesia machine delivering a fresh gas flow of 12 l min-1. The inspired O2 concentration was set at 100%. End of preoxygenation FEO2=90%
Positive Pressure Ventilation (PPV)
n=47 Participants
PPV : positive pressure ventilation : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) without PEEP. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=0 cmH2O End of preoxygenation FEO2=90% PPV : positive pressure ventilation: Inspiratory pressure support ventilation (12 cmH2O) without PEEP
PPV + PEEP
n=50 Participants
PEEP : PPV + PEEP : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) with PEEP at 6 cmH2O. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=6 cmH2O End of preoxygenation FEO2=90% PEEP : PPV + PEEP: Inspiratory pressure support ventilation (12 cmH2O) with PEEP (6 cmH2O)
Discomfort of the Preoxygenation Phase Self Reported by the Patient
0 millimeters
Interval 0.0 to 18.0
8 millimeters
Interval 0.0 to 20.0
0 millimeters
Interval 0.0 to 10.0

Adverse Events

Spontaneous Breathing (SB)

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Positive Pressure Ventilation (PPV)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

PPV + PEEP

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Spontaneous Breathing (SB)
n=49 participants at risk
preoxygenation through a face mask firmly applied and connected to the anaesthesia machine delivering a fresh gas flow of 12 l min-1. The inspired O2 concentration was set at 100%. End of preoxygenation FEO2=90%
Positive Pressure Ventilation (PPV)
n=47 participants at risk
PPV : positive pressure ventilation : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) without PEEP. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=0 cmH2O End of preoxygenation FEO2=90% PPV : positive pressure ventilation: Inspiratory pressure support ventilation (12 cmH2O) without PEEP
PPV + PEEP
n=50 participants at risk
PEEP : PPV + PEEP : preoxygenation with noninvasive positive inspiratory pressure ventilation (12 cmH2O) with PEEP at 6 cmH2O. Preoxygenation through a face mask firmly applied and connected to the anaesthesia machine - non invasive inspiratory ventilation mode - inspiratory trigger sensitivity was set at -2 l min-1, the adjustable pressure limiting valve was opened, and maximal airway pressure was limited at 18 cmH2O - PEEP=6 cmH2O End of preoxygenation FEO2=90% PEEP : PPV + PEEP: Inspiratory pressure support ventilation (12 cmH2O) with PEEP (6 cmH2O)
Nervous system disorders
Anxiety
2.0%
1/49 • Number of events 1
0.00%
0/47
0.00%
0/50

Additional Information

Pr Jean-Luc Hanouz

CaenUH

Phone: 33 2 31 06 47 36

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place